What is Calcivis?
CALCIVIS is a pioneering dental technology company headquartered in Edinburgh, United Kingdom. The company is focused on revolutionizing dental diagnostics with its advanced imaging system. This technology enables dentists to detect active tooth decay in its nascent stages, facilitating the application of preventive treatments rather than more invasive procedures. The system aims to shift the paradigm in dental care towards proactive and conservative interventions, improving patient outcomes and potentially reducing long-term treatment costs.
How much funding has Calcivis raised?
Calcivis has raised a total of $26.8M across 9 funding rounds:
Grant
$505K
Private Equity
$1.3M
Multiple Rounds
$13.2M
Private Equity
$1.3M
Other Financing Round
$2.2M
Unspecified
$2M
Other Financing Round
$6.3M
Grant (2014): $505K, investors not publicly disclosed
Private Equity (2014): $1.3M led by Archangel Informal Investment
Private Equity (2015): $7M supported by Archangel Investors
Grant (2015): $3M, investors not publicly disclosed
Other Financing Round (2015): $3.2M backed by European Commission
Private Equity (2017): $1.3M with participation from Julz Co, LLC and Archangel Investors
Other Financing Round (2019): $2.2M led by European Commission
Unspecified (2021): $2M supported by Archangels, Lynx Financial, and Scottish Enterprise
Other Financing Round (2024): $6.3M featuring Maven Capital Partners UK and Scottish National Investment Bank
Key Investors in Calcivis
Maven Capital Partners UK
Maven Capital Partners UK LLP is a venture capital and private equity firm known for its investment in growing businesses. Their participation suggests a belief in Calcivis's market potential and scalability.
Scottish National Investment Bank
The Scottish National Investment Bank provides long-term capital for businesses and projects across Scotland, focusing on innovation and economic development. Their investment highlights support for Scottish-based technological advancements.
Archangel Investors
Archangel Investors is an angel investment group that typically backs early-stage companies with high growth potential. Their continued involvement indicates strong confidence in Calcivis's trajectory and management team.
What's next for Calcivis?
The recent major enterprise-level funding and strategic investment signal a significant growth phase for Calcivis. This capital infusion is expected to accelerate the company's product development, expand its market reach, and further refine its imaging technology. With a clear focus on innovation and strategic partnerships, Calcivis is poised to solidify its position in the dental technology sector, driving forward the adoption of advanced diagnostic tools in clinical practice.
See full Calcivis company page
